CAS 62613-82-5
:Oxiracetam
- (S)-oxiracetam
- 1-Pyrrolidineacetamide, 4-hydroxy-2-oxo-
- 2-(4-Hydroxy-2-Oxopyrrolidin-1-Yl)Acetamide
- 4-Hydroxy-2-oxo-1-pyrrolidineacetamide
- 4-Hydroxy-2-oxopyrrolidine-N-acetamide
- 4-Hydroxypyrrolidone-2-acetamide
- Cgp 21690
- Cgp 21690E
- Ct 848
- Hydroxypiracetam
- Isf 2522
- Neuractiv
- Neuromet
- Oxyracetam
- Oxiracetam
- 4-hydroxy-2-oxo-1-pyrrolidineacetamid
- Oxriacetam
- 4-1-lydroxypiracetan
- Neurome
- isf2522
- 2-(4-HYDROXY-PYRROLIDINO-2-ON-1-YL)ETHYL ACETATE
- Voir plus de synonymes
Oxiracetam
CAS :Formule :C6H10N2O3Degré de pureté :>96.0%(GC)(N)Couleur et forme :White to Almost white powder to crystalMasse moléculaire :158.16Oxiracetam (4-Hydroxy-2-oxo-1-pyrrolidineacetamide)
CAS :Lactams, nesoiFormule :C6H10N2O3Couleur et forme :PowderMasse moléculaire :158.069141-Pyrrolidineacetamide, 4-hydroxy-2-oxo-
CAS :Formule :C6H10N2O3Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :158.1552Oxiracetam
CAS :Oxiracetam (ISF2522), a cyclic derivative of gamma-aminobutyric acid (GABA), is utilized for the treatment of cognitive impairments.
Formule :C6H10N2O3Degré de pureté :99.67%Couleur et forme :White Crystalline PowderMasse moléculaire :158.164-Hydroxy-2-Oxopyrrolidine-N-Acetamide
CAS :4-Hydroxy-2-Oxopyrrolidine-N-AcetamideDegré de pureté :98%Masse moléculaire :158.16g/molOxiracetam
CAS :Formule :C6H10N2O3Couleur et forme :White To Off-White SolidMasse moléculaire :158.16Oxiracetam
CAS :Formule :C6H10N2O3Degré de pureté :≥ 98.0%Couleur et forme :White to off-white crystalline powderMasse moléculaire :158.16Oxiracetam
CAS :Produit contrôléApplications Nootropic. Analog of Piracetam with psychostimulant activity.
References Son, J., et al.: J. Pharm. Biomed. Anal., 36, 657 (2004), Hlinak, Z., et al.: Behaviour. Brain Res., 161, 213 (2005),Formule :C6H10N2O3Couleur et forme :NeatMasse moléculaire :158.16Oxiracetam
CAS :Oxiracetam is a nootropic drug that has been shown to have neuroprotective properties. It is an ester hydrochloride of the parent compound oxiracetam, which has been found to have a number of pharmacological effects, including modulation of voltage-dependent calcium channels and inhibition of brain damage due to hypoxia or ischemia. Oxiracetam may be used in combination therapy with other drugs for the treatment of neurological disorders such as Alzheimer's disease and Parkinson's disease. Oxiracetam binds to hydroxyl groups on proteins in the brain and increases the activity of choline acetyltransferase, an enzyme involved in acetylcholine synthesis. This leads to increased production of acetylcholine, which is important for memory and learning. Oxiracetam also inhibits protein degradation by enhancing phosphorylation in neurons, leading to improved mental performance. The analytical method for measuring oxiracetam concentration in human serum is HPLC with fluorescence detection
Formule :C6H10N2O3Degré de pureté :Min. 95%Couleur et forme :White PowderMasse moléculaire :158.16 g/mol2-(4-hydroxy-2-oxopyrrolidin-1-yl)acetamide
CAS :Formule :C6H10N2O3Degré de pureté :97%Couleur et forme :SolidMasse moléculaire :158.157












